Lantheus Holdings (LNTH) Cost of Revenue (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Cost of Revenue came in at $146.4 million in Q1 2026, up 8.4% year-on-year from $135.1 million in Q1 2025, and down 11.75% on a QoQ basis from $165.9 million in Q4 2025.

Lantheus Holdings (LNTH) Cost of Revenue (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Cost of Revenue data on file, last reported at $146.4 million in Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 8.4% year-over-year to $146.4 million in Q1 2026; TTM through Mar 2026 was $611.0 million, a 10.58% increase from a year earlier, with the FY2025 full-year figure at $599.7 million, up 9.9% from the prior year.
  • Cost of Revenue for Q1 2026 stood at $146.4 million, down from $165.9 million in the prior quarter.
  • Over the last five years, Cost of Revenue for LNTH reached as high as $223.7 million in Q1 2023 and fell as low as $79.8 million in Q1 2022.
  • Historically, Cost of Revenue has averaged $131.3 million across 5 years, with a median of $135.1 million in 2025.
  • Across the five-year window, Cost of Revenue soared 180.3% in 2023 and plunged 42.72% in 2024, its largest moves.
  • Year by year, Cost of Revenue stood at $96.0 million in 2022, then rose by 29.31% to $124.1 million in 2023, then grew by 14.85% to $142.6 million in 2024, then increased by 16.38% to $165.9 million in 2025, then slipped by 11.75% to $146.4 million in 2026.
  • Per Business Quant data, the three most recent Cost of Revenue figures were $146.4 million in Q1 2026, $165.9 million in Q4 2025, and $161.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 2.01 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 641.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 2.59 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 133.40 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 2.36 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 13.80 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 586.00 Mn
10 Lantheus Holdings 7.04 Bn 6.54 Bn 230.92 Mn 146.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 146.41 Mn
Mar 31, 2026 146.41 Mn
Dec 31, 2025 165.91 Mn
Dec 31, 2025 165.91 Mn
Sep 30, 2025 161.65 Mn
Sep 30, 2025 161.65 Mn
Jun 30, 2025 137.03 Mn
Jun 30, 2025 137.03 Mn
Mar 31, 2025 135.06 Mn
Mar 31, 2025 135.06 Mn
Dec 31, 2024 142.57 Mn
Dec 31, 2024 142.57 Mn
Sep 30, 2024 136.61 Mn
Sep 30, 2024 136.61 Mn
Jun 30, 2024 138.32 Mn
Jun 30, 2024 138.32 Mn
Mar 31, 2024 128.13 Mn
Mar 31, 2024 128.13 Mn
Dec 31, 2023 124.13 Mn
Dec 31, 2023 124.13 Mn